High-performance liquid chromatographic determination of aminosalicylate, sulfapyridine and their metabolites. Its application for pharmacokinetic studies with salicylazosulfapyridine in man.

Suppr

超能文献

作者信息

Fischer C, Klotz U

出版信息

J Chromatogr. 1979 Feb 21;162(2):237-43. doi: 10.1016/s0378-4347(00)81919-2.

DOI:10.1016/s0378-4347(00)81919-2

PMID:33196

Abstract

摘要

相似文献

High-performance liquid chromatographic determination of aminosalicylate, sulfapyridine and their metabolites. Its application for pharmacokinetic studies with salicylazosulfapyridine in man.

J Chromatogr. 1979 Feb 21;162(2):237-43. doi: 10.1016/s0378-4347(00)81919-2.

Determination of sulfapyridine and its major metabolites in plasma by high pressure liquid chromatography.

J Chromatogr. 1978 Jul 1;146(1):157-62. doi: 10.1016/s0378-4347(00)81302-x.

Relationship between the acetylator phenotype, plasma sulfapyridine levels and adverse effects during treatment with salicylazosulfapyridine in patients with chronic bowel diseases.慢性肠道疾病患者使用柳氮磺胺吡啶治疗期间乙酰化表型、血浆磺胺吡啶水平与不良反应之间的关系。

Isr J Med Sci. 1990 Jan;26(1):31-4.

Determination of salicylazosulphapyridine and sulphapyridine in plasma using high-performance liquid chromatography.

J Chromatogr. 1978 Jul 21;154(2):321-4. doi: 10.1016/s0021-9673(00)98488-7.

A rapid method for the simultaneous determination of the major metabolites of sulphasalazine in plasma.

J Chromatogr. 1983 May 13;274:393-7. doi: 10.1016/s0378-4347(00)84450-3.

Role of the intestinal flora in the acetylation of sulfasalazine metabolites.肠道菌群在柳氮磺胺吡啶代谢物乙酰化中的作用。

Biochem Pharmacol. 1987 Nov 1;36(21):3772-4. doi: 10.1016/0006-2952(87)90034-7.

Sulfapyridine appearance in plasma after salicylazosulfapyridine. Another simple measure of intestinal transit.

Gastroenterology. 1986 Aug;91(2):396-400. doi: 10.1016/0016-5085(86)90574-3.

[Estimations of the serum levels of sulfapyridine on patients treated with sulfasalazin (author's transl)].

Dtsch Z Verdau Stoffwechselkr. 1982;42(1):14-9.

Acetylator phenotype and serum levels of sulfapyridine in patients with inflammatory bowel disease.

Eur J Clin Pharmacol. 1981;21(3):243-50. doi: 10.1007/BF00627927.

High-performance liquid chromatographic assay of sulfapyridine and acetylsulfapyridine in biological fluids.

J Pharm Sci. 1978 Sep;67(9):1250-3. doi: 10.1002/jps.2600670916.

引用本文的文献

Degradation Study on Sulfasalazine and a Validated HPLC-UV Method for its Stability Testing.柳氮磺胺吡啶降解研究及一种用于其稳定性测试的经过验证的高效液相色谱-紫外检测法

Sci Pharm. 2014 Jan 12;82(2):295-306. doi: 10.3797/scipharm.1311-15. Print 2014 Apr-Jun.

The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications.药物遗传学在抗癫痫药物代谢中的作用：药代动力学及治疗学意义

Clin Pharmacokinet. 2007;46(4):271-9. doi: 10.2165/00003088-200746040-00001.

The influence of multiple oral doses of zileuton on the steady-state pharmacokinetics of sulfasalazine and its metabolites, sulfapyridine and N-acetylsulfapyridine.多次口服齐留通对柳氮磺胺吡啶及其代谢产物磺胺吡啶和N - 乙酰磺胺吡啶稳态药代动力学的影响。

Clin Pharmacokinet. 1995;29 Suppl 2:98-104. doi: 10.2165/00003088-199500292-00014.

Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man.人体中某些磺胺类药物乙酰化表型及药代动力学的测定

Clin Pharmacokinet. 1980 May-Jun;5(3):274-94. doi: 10.2165/00003088-198005030-00006.

Survey of the human acetylator polymorphism in spontaneous disorders.自发性疾病中人类乙酰化多态性的调查。

J Med Genet. 1984 Aug;21(4):243-53. doi: 10.1136/jmg.21.4.243.

Acetylator phenotype and serum levels of sulfapyridine in patients with inflammatory bowel disease.

Eur J Clin Pharmacol. 1981;21(3):243-50. doi: 10.1007/BF00627927.

Saliva: plasma concentration relationships for sulphapyridine following sulphasalazine administration to normal volunteers and patients with inflammatory bowel disease.唾液：对正常志愿者和炎症性肠病患者给予柳氮磺胺吡啶后磺胺吡啶的唾液与血浆浓度关系。

Br J Clin Pharmacol. 1980 Jan;9(1):91-4. doi: 10.1111/j.1365-2125.1980.tb04802.x.

Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.类风湿关节炎患者血浆及滑液中柳氮磺胺吡啶及其两种代谢产物的浓度

Rheumatol Int. 1985;5(6):247-51. doi: 10.1007/BF00541351.

5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?

Drugs. 1986;32 Suppl 1:27-34. doi: 10.2165/00003495-198600321-00006.

Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.柳氮磺胺吡啶、其代谢产物及其他5-氨基水杨酸前体药物的临床药代动力学。

Clin Pharmacokinet. 1985 Jul-Aug;10(4):285-302. doi: 10.2165/00003088-198510040-00001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验